WuXi AppTec Co., Ltd. (2359.HK)
| Previous Close | 37.950 |
| Open | 37.800 |
| Bid | 37.250 x 0 |
| Ask | 37.300 x 0 |
| Day's Range | 37.150 - 38.200 |
| 52 Week Range | 32.600 - 103.600 |
| Volume | |
| Avg. Volume | 9,126,034 |
| Market Cap | 137.891B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 10.86 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.99 (2.61%) |
| Ex-Dividend Date | Jun 05, 2023 |
| 1y Target Est | N/A |
- Reuters
Exclusive-China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senators
(Reuters) -U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing without consent, according to two sources. The U.S. government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China's military, and the proposed legislation would restrict U.S. government funds going to those Chinese companies. The classified briefing to about a dozen senators was led by the FBI, the State Department and the Office of the Director of National Intelligence.
- Reuters
Biotech trade association to split with China's WuXi AppTec
(Reuters) -A Washington-based global trade association representing biotechnology companies is taking steps to "separate" from Chinese member Wuxi AppTec , according to a letter from its new CEO on Wednesday. The Biotechnology Innovation Organization (BIO) also said it would support proposed legislation that restricts U.S. business with WuXi AppTec and other biotech companies of concern, changing its position from last month. WuXi AppTec, in a letter to BIO dated Tuesday that it provided to Reuters, said it was ending its membership in the organization.
- Reuters
US Senate bill targeting China's BGI, WuXi AppTec moves forward
(Reuters) -The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with Chinese biotech companies like BGI and WuXi AppTec on national security grounds. The bill is designed to keep Americans' personal health and genetic information from foreign adversaries. The bill has spurred deep concern among investors, driving a sell-off in the shares of WuXi AppTec when news of its introduction first reached Chinese markets last month.
